Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

Coagulation

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

Preparation and Reactions of Thiols

Preparation and Reactions of Thiols

Thiols are prepared using the hydrosulfide anion as a nucleophile in a nucleophilic substitution reaction with alkyl halides. For instance, bromobutane reacts with sodium hydrosulfide to give butanethiol.

Intracellular Signaling Affects Focal Adhesions

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<i>In vitro</i> characterization of rare anti-α<sub>IIb</sub>β<sub>3</sub> isoantibodies produced by patients with Glanzmann thrombasthenia that severely block fibrinogen binding and generate procoagulant platelets via complement activation.

Research and practice in thrombosis and haemostasis·2024

Same author

Tinzaparin for venous thromboembolism in patients with renal impairment: a single-centre, prospective pilot study.

Internal medicine journal·2020

Same author

Procoagulant platelets: Laboratory detection and clinical significance.

International journal of laboratory hematology·2020

Same author

Platelets as Biomarkers of Coronary Artery Disease.

Seminars in thrombosis and hemostasis·2016

Same author

Enumeration of extracellular vesicles by a new improved flow cytometric method is comparable to fluorescence mode nanoparticle tracking analysis.

Nanomedicine : nanotechnology, biology, and medicine·2016

Same author

Necrotic platelets provide a procoagulant surface during thrombosis.

Blood·2015

Search research articles

Related Experiment Video

Updated: May 15, 2026

Extracellular Vesicle Tissue Factor Activity Assay

Extracellular Vesicle Tissue Factor Activity Assay

Published on: December 29, 2023

Tissue factor de-encryption, thrombus formation, and thiol-disulfide exchange.

Vivien M Y Chen¹

¹Division of Adult Cancer Program, Lowy Cancer Research Centre, Faculty of Medicine, University of New South Wales, Sydney, Australia. vivien.chen@unsw.edu.au

Seminars in Thrombosis and Hemostasis

|January 18, 2013

Summary

Tissue factor (TF) initiates blood coagulation but is typically inactive in circulation. Research shows thiol-disulfide exchange activates TF, highlighting its role in thrombosis and potential as an antithrombotic target.

More Related Videos

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

Related Experiment Videos

Last Updated: May 15, 2026

Extracellular Vesicle Tissue Factor Activity Assay

Extracellular Vesicle Tissue Factor Activity Assay

Published on: December 29, 2023

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

Area of Science:

Biochemistry
Hematology
Molecular Biology

Background:

Tissue factor (TF) complexed with factor VIIa (FVIIa) initiates blood coagulation.
Traditionally, circulating FVIIa separation from subendothelial TF prevented spontaneous thrombosis.
TF is present in healthy plasma and contributes to thrombin generation post-activation.

Purpose of the Study:

Investigate the mechanism of TF activation and its role in thrombosis.
Explore the role of disulfide bonds and thiol-disulfide exchange in TF activity.
Identify potential antithrombotic targets related to TF activation.

Main Methods:

Analysis of TF encryption/de-encryption mechanisms.
Investigated the role of phosphatidylserine (PS) exposure in TF activity.
Examined thiol-disulfide exchange and oxidoreductase involvement in TF activation.

Main Results:

TF exists in an "encrypted" (inactive) state, requiring de-encryption for activity.
Phosphatidylserine exposure is insufficient for full TF activation.
Thiol-disulfide exchange, particularly involving extracellular protein disulfide isomerase, is crucial for TF activation and thrombus initiation.

Conclusions:

TF activation is regulated by allosteric disulfide bonds and thiol-disulfide exchange.
Extracellular protein disulfide isomerase plays a key role in early thrombus initiation.
TF activation mechanisms offer potential targets for novel antithrombotic therapies.